The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Biofilm formation: mechanistic insights and therapeutic targets
Open accessAbstract
Biofilms are complex multicellular communities formed by bacteria, and their extracellular polymeric substances are observed as surface-attached or non-surface-attached aggregates. Many types of bacterial species found in living hosts or environments can form biofilms. These include pathogenic bacteria such as Pseudomonas, which can act as persistent infectious hosts and are responsible for a wide range of chronic diseases as well as the emergence of antibiotic resistance, thereby making them difficult to eliminate. Pseudomonas aeruginosa has emerged as a model organism for studying biofilm formation. In addition, other Pseudomonas utilize biofilm formation in plant colonization and environmental persistence. Biofilms are effective in aiding bacterial colonization, enhancing bacterial resistance to antimicrobial substances and host immune responses, and facilitating cell‒cell signalling exchanges between community bacteria. The lack of antibiotics targeting biofilms in the drug discovery process indicates the need to design new biofilm inhibitors as antimicrobial drugs using various strategies and targeting different stages of biofilm formation. Growing strategies that have been developed to combat biofilm formation include targeting bacterial enzymes, as well as those involved in the quorum sensing and adhesion pathways. In this review, with Pseudomonas as the primary subject of study, we review and discuss the mechanisms of bacterial biofilm formation and current therapeutic approaches, emphasizing the clinical issues associated with biofilm infections and focusing on current and emerging antibiotic biofilm strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Taken together, the molecular mechanisms elucidated by Wang et al [33] illustrate how biofilms protect P. aeruginosa through multiple coordinated layers of defense”
From The Elimination Effect of Medical-Grade Honey on Pseudomonas aeruginosa Biofilms: A Systematic Review and Meta-Analysis (2025) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multistate point-prevalence survey of health care-associated infections
Magill, S. S., Edwards, J. R., Bamberg, W., Beldavs, Z. G., Dumyati, G., Kainer, M. A., Lynfield, R., Maloney, M., McAllister-Hollod, L., Nadle, J., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1306801 · Cited by 3,931
Hidron, A. I., Edwards, J. R., Patel, J., Horan, T. C., Sievert, D. M., Pollock, D. A., Fridkin, S. K., & National Healthcare Safety Network Team and Participating National Healthcare Safety Network Facilities (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/591861 · Cited by 3,724
Weiner, L. M., Webb, A. K., Limbago, B., Dudeck, M. A., Patel, J., Kallen, A. J., Edwards, J. R., & Sievert, D. M. (2016) · Infection Control & Hospital Epidemiology · doi:10.1017/ice.2016.174 · Cited by 1,313 · cited 1×
“…( P. aeruginosa ), is one of the most common causes of nosocomial infections; these infections mainly manifest as pneumonia, suppuration of exposed wounds, and bacteraemia, and Pseudomonas is second only to Staphylococcus aureus ( S. aureus ) in terms of causing nosocomial infection [18, 19].”
BackgroundHajishengallis, G., Liang, S., Payne, M. A., Hashim, A., Jotwani, R., Eskan, M. A., McIntosh, M. L., Alsam, A., Kirkwood, K. L., Lambris, J. D., et al. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2011.10.006 · Cited by 1,154
Metabolite-enabled eradication of bacterial persisters by aminoglycosides
Allison, K. R., Brynildsen, M. P., & Collins, J. J. (2011) · Nature · doi:10.1038/nature10069 · Cited by 1,025 · cited 1×
“This innovative approach is effective at enhancing the treatment of chronic infections, as evidenced by positive outcomes in mouse models of urinary tract infection [123].”
BackgroundSkeletal infections: microbial pathogenesis, immunity and clinical management
Masters, E. A., Ricciardi, B. F., Bentley, K. L. D. M., Moriarty, T. F., Schwarz, E. M., & Muthukrishnan, G. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00686-0 · Cited by 735
The role of the microbiota in periodontal disease
Curtis, M. A., Diaz, P. I., & Van Dyke, T. E. (2020) · Periodontology 2000 · doi:10.1111/prd.12296 · Cited by 698
Therapeutic Potential of Biofilm-Dispersing Enzymes
Kaplan, J. B. (2009) · The International Journal of Artificial Organs · doi:10.1177/039139880903200903 · Cited by 217 · cited 1×
“Staphylococcus epidermidis [16] LuxS”
Bowel Biofilms: Tipping Points between a Healthy and Compromised Gut?
Tytgat, H. L. P., Nobrega, F. L., van der Oost, J., & de Vos, W. M. (2019) · Trends in Microbiology · doi:10.1016/j.tim.2018.08.009 · Cited by 144
Kaplan, J. B., Mlynek, K. D., Hettiarachchi, H., Alamneh, Y. A., Biggemann, L., Zurawski, D. V., Black, C. C., Bane, C. E., Kim, R. K., & Granick, M. S. (2018) · PLOS ONE · doi:10.1371/journal.pone.0205526 · Cited by 96
Cited by
Hariyudo, H., Benokri, H. R., Wirohadidjojo, Y. W., Herdini, C., Budiyanto, A., & Nugroho, D. B. (2025) · Journal of Clinical Medicine Research · doi:10.14740/jocmr6312 · Cited by 1
Metadata
- Authors
- Wang, X., Liu, M., Yu, C., Li, J., & Zhou, X.
- Venue
- Molecular Biomedicine
- Published
- 2023-12-15
- Volume
- 4
- Issue
- 1
- Pages
- 49-49
- ISSN
- 2662-8651 (ISSN-L)
- OpenAlex
- W4389761918
- Cited by
- 173
- References
- 10
- FWCI
- 12.93
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Biofilm formation: mechanistic insights and therapeutic targets. https://app.cochat.ai/papers/10.1186/s43556-023-00164-w
- The paper
- Wang, X., Liu, M., Yu, C., Li, J., & Zhou, X. (2023). Biofilm formation: mechanistic insights and therapeutic targets. Molecular Biomedicine. https://doi.org/10.1186/s43556-023-00164-w
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.